Searchable abstracts of presentations at key conferences in endocrinology
Endocrine Abstracts (2025) 110 P57 | DOI: 10.1530/endoabs.110.P57

1IRCCS Istituto Auxologico Italiano, Endocrinology Department of Endocrine and Metabolic Diseases, Milann, Italy; 2Department of Medical Biotechnology and Translational Medicine, Milan, Italy; 3ASST Grande Ospedale Metropolitano Niguarda, Unit of Endocrinology, Milan, Italy; 4Fondazione IRCCS Cà Granda-Ospedale Maggiore, Unit of Endocrinology, Milan, Italy; 5IRCCS Ospedale Casa Sollievo della Sofferenza, Unit of Endocrinology and Diabetology, San Giovanni Rotondo (FG), Italy; 6University-Hospital S. Maria della Misericordia, Unit of Endocrinology and Metabolism, Udine, Italy; 7University of Milan, Department of Biomedical, Surgical and Dental Sciences, Milano, Italy; 8University of Milan, Department of Clinical Sciences and Community Health, Milano, Italy


JOINT1418

Objective: Mild autonomous cortisol secretion (MACS) is associated with increased risk of vertebral fractures (VFx). However, the impact of recovery from MACS on bone health remains unclear.

Design: Retrospective Longitudinal Intervention Study (Study 1): A total of 53 patients with MACS were followed for 35.2±18.6 months (mean±S.D.). Among these, 31 patients underwent surgery (Study 1-GroupA), while 22 patients received conservative treatment (Study 1-GroupB). Prospective Randomized Study (Study 2): Fifty-one outpatients with MACS were randomly assigned to either adrenalectomy (Study 2-GroupA, 21 patients, 67% females, age 63 [56.5–72.5]) or a conservative approach (Study 2-GroupB, 28 patients, 78% females, age 69 [61–73]) and were followed for 24 months.

Methods: MACS was diagnosed in patients with adrenal incidentalomas>1 cm and cortisol after 1-mg dexamethasone suppression test (F-1 mgDST)≥1.8 μg/dL. At baseline and at the end of the follow-up we assessed: mineral metabolism, bone mineral density (BMD) at the lumbar spine (LS), total hip (TH) and femoral neck (FN) using Dual-energy X-ray Absorptiometry, and clinical and morphometric vertebral fractures (VFx).

Results: Study 1: Study 1-GroupB showed an increased incidence of VFx (n=11) at the end of the follow-up when compared to Study1-GroupA (n=3, P<0.05). In both groups, BMD at LS, FN and TH were similar at baseline and at the end of follow-up. In Study 1-GroupB, a new VFx occurred in 50% of patients, including 2 out of the 5 patients treated with bisphosphonates; in GroupA, 3 patients (9.7%) experienced incident VFx, all having a prevalent VFx at baseline. Study 2: Patients in both groups were comparable for demographic features (age, sex, BMI), adenoma’s size, cortisol secretion parameters (F-1 mgDST, urinary free cortisol, ACTH), prevalent VFx and BMD at baseline. After 24 months, in Study 2-GroupA, we observed significant increases in calcium and phosphate levels compared to baseline (P=0.03 and P=0.04, respectively). In Study 2-GroupB, no significant changes were noted when comparing baseline values with those after 24 months. Additionally, at the end of follow up, BMD remained stable across both groups. However, Study 2-GroupB showed a significantly higher incidence (n=7, 25%) of VFx by the end of the follow-up period compared to Study 2-GroupA (n=1, 4.8%, P=0.04).

Conclusions: In patients with unilateral adrenal incidentalomas and MACS, adrenalectomy significantly reduces the risk of vertebral fractures.

Volume 110

Joint Congress of the European Society for Paediatric Endocrinology (ESPE) and the European Society of Endocrinology (ESE) 2025: Connecting Endocrinology Across the Life Course

European Society of Endocrinology 
European Society for Paediatric Endocrinology 

Browse other volumes

Article tools

My recent searches

No recent searches